Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 12Hematologic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 5Urinary Bladder Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Myasthenia Gravis 3Multiple Myeloma 3Lung Neoplasms 3Kidney Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Heart Failure 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Diabetes Mellitus, Type 2 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × INDUSTRY × Pancreatic Adenocarcinoma × Clear all
NCT06157671 2025-03-07

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

Adenocyte, LLC

Enrolling by invitation
1,000 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡